Medicare Doughnut Hole

(redirected from Medicare Part D Coverage Gap)
Also found in: Wikipedia.
Formally known as the Medicare Part D Coverage Gap. The difference between the initial coverage limit and the catastrophic coverage threshold, as described in the Medicare Part D prescription drug program. After a Medicare beneficiary surpasses the prescription drug coverage limit, the Medicare beneficiary is financially responsible for the entire cost of prescription drugs until the expense reaches the catastrophic coverage threshold, fancifully likened to a doughnut which provides pleasure to the consumer until he hits the centre—no joy—then returns to the happy part
References in periodicals archive ?
"Effect of the Medicare Part D Coverage Gap on Medication Use among Patients with Hypertension and Hyperlipidemia." Annals of Internal Medicine 156 (11): 776, 84, W-263, W-264, W-265, W-266, W-267, W-268, W-269.
WASHINGTON -- Starting next year, the nation's pharmaceutical manufacturers will provide 50% discounts on the cost of covered branded prescription drugs to beneficiaries in the Medicare Part D coverage gap, the so-called doughnut hole.
* Require pharmaceutical manufacturers to offer a 50 percent discount on brand-name prescriptions filled in the Medicare Part D coverage gap beginning in 2011, and begin phasing in federal subsidies for generic prescriptions filled in the Medicare Part D coverage gap.
* Begin phasing in federal subsidies for brand-name prescriptions filled in the Medicare Part D coverage gap.
"Medicare Part D Coverage Gap: Race, Gender, and Cost-Related Medication Nonadherence." Social Work in Public Health 30 (6): 473-85.
"Effects of Medicare Part D Coverage Gap on Medication Adherence." The American Journal of Managed Care 19 (6): e214-24.
"Effects of Medicare Part D Coverage Gap on Medication and Medical Treatment among Elderly Beneficiaries with Depression." Archives of General Psychiatry 69 (7): 6729.
Understanding the Effects of the Medicare Part D Coverage Gap in 2008 and 2009: Cost and Consequences Prior to Improvements in Coverage Established by the 2010 Health Reform Law.
We examined the effect of the Medicare Part D coverage gap on drug costs and adherence among beneficiaries with diabetes in two large health systems offering MAPD plans.
Full browser ?